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Abstract
Bacterial resistance to antibiotics is a major therapeutic problem. Bacteria use the same mechanisms for developing resistance to anti-
biotics as they do for developing resistance to biocide compounds present in some cleaning and personal care products. Root–nodula-
tion–cell division (RND) family efﬂux pumps are a common means of multidrug resistance, and induction of their expression can explain
the observed cross-resistance found between antibiotics and biocides in laboratory strains. Hence, there is a relationship between the
active chemicals used in household products, organic solvents and antibiotics. The widespread use of biocide-containing modern-day
household products may promote the development of microbial resistance and, in particular, cross-resistance to antibiotics.
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Since the ﬁrst high-yield production of penicillin, antibiotics
have had a profound impact on human health and society.
The recent development of personal care and household
cleaning products that contain antibacterial compounds has
inﬂuenced personal hygiene. The former may have contri-
buted to preventing microbial infection on the skin of indivi-
duals, and the latter have helped to combat microbes in the
environment. The widespread use of antibiotics, and personal
care/cleaning products that contain antibacterial agents, has
created an optimistic view that many potential bacterial
infections can be defeated. The indiscriminate use of these
products, however, has resulted in selective pressure
enhancing the development of antibiotic resistance in
microbes. As a consequence, drug-resistant pathogens are
becoming increasingly pervasive [1]. The resurgence of
tuberculosis and other infectious diseases exemplify the risks
associated with evolving drug resistance.
Four strategies that lead to antimicrobial drug resistance
are commonly used by bacteria and other cells: (i) the target
enzyme of an antibiotic may mutate and acquire resistance;
(ii) new enzymes may evolve that degrade the antibiotic; (iii)
entry of antibiotics might be excluded or limited because of
cell membrane modiﬁcations; and (iv) the antibiotic may be
exported from the cell [2].
Multidrug resistance (MDR) is a phenomenon whereby a
host displays intrinsic resistance to a broad range of chemi-
cals against which it has never previously been exposed.
Speciﬁcally, MDR efﬂux transporters actively extrude chemi-
cals out of the cell with a remarkably broad range of sub-
strate speciﬁcity, and are typically most effective when
combined with other resistance mechanisms [3]. Thus, chem-
ical agents are effectively prevented from reaching concentra-
tions lethal to the host.
MDR efﬂux transporters have been identiﬁed in eukary-
otes, bacteria and archaea, and are classiﬁed into ﬁve major
groups [4] (Fig. 1): (i) the ATP-binding cassette transporters,
which couple the hydrolysis of ATP to the export of sub-
strate; (ii) the major facilitator superfamily transporters; (iii)
the small multidrug resistance family transporters; (iv) the
root–nodulation–division (RND) family transporters, all of
which couple the energy stored in a transmembrane proton
gradient to export substrate; and (v) the multi-antimicrobial
extrusion family, which couples either a proton or sodium
gradient to export substrate. In Gram-negative bacteria,
which contain both inner (cytoplasmic) and outer mem-
branes separated by a periplasmic space, the outer mem-
brane does not support a protonmotive force. Thus,
bacterial RND transporters utilize the protonmotive force
across the cytoplasmic membrane to extrude substrate. The
complex is typically composed of an energy-coupled integral
membrane protein pump associated with an outer membrane
protein that enters into the periplasm and produces an exit
duct, and a third element that acts as an adaptor and guaran-
tees its structural integrity [5]. Therefore, bacterial RND
efﬂux systems span the periplasm and both inner and outer
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membranes, thus clearing toxic chemicals from intracellular
compartments.
Numerous recent studies have indicated that the use of
antimicrobial household cleaning agents can select for organ-
isms with adapted efﬂux pump resistance mechanisms [6–9].
Pseudomonas aeruginosa is normally resistant to the bisphenol
compounds that are often added to home cleaning and
hygiene products; the resistance is brought about by the
active efﬂux of the compounds by the MexAB–OprM RND
family efﬂux pump. Chuanchuen et al. have shown that P. aeru-
ginosa strains lacking the MexAB–OprM pump can be selec-
tively pressured by bisphenol compound exposure to
hyperexpress another RND efﬂux pump family member
(MexCD–OprJ) and subsequently become multidrug-resistant
[7,8]. Further studies using the human enteric pathogen
E. coli O157 have shown that sublethal exposure to quater-
nary ammonium compounds and bisphenols can result in
adaptive resistance to various antimicrobial agents, including
tetracycline, chloramphenicol and biocides [6]. In E. coli, the
proposed mechanism of bisphenol resistance and cross-resis-
tance is the overexpression of the active efﬂux pump AcrAB
[9]. In a more recent study, using the reverse hypothesis that
antibiotic-resistant organisms become tolerant to other anti-
bacterial agents owing to the action of efﬂux pumps, Thorr-
old et al. implicated efﬂux pump activity in Salmonella and
E. coli in causing reduced susceptibility to household antimi-
crobial cleaning agents [10]. A promising strategy for
addressing MDR in Gram-negative bacteria, therefore, aims
to counteract RND efﬂux pumps, potentially halting the
clearance of drugs from the cellular milieu.
Many pathogenic and non-pathogenic microorganisms,
such as P. aeruginosa, E. coli, Salmonella spp. and Pseudomonas
putida, can grow in the presence of selected solvents and
antibacterials; in some extreme cases, as with P. putida DOT-
T1E, growth can reach high cell densities in even 1% (v/v) of
a number of linear, cyclic and aromatic hydrocarbons and
other compounds (e.g. organic alcohols and phthalates),
many of which are present in available household cleaning
products [11].
P. putida DOT-T1E is therefore an interesting model sys-
tem, and several laboratories have established that three
general mechanisms are involved in the tolerance of this
strain to toxic chemicals [12,13]. One of these mechanisms
is a set of physical barriers intended to increase the rigidity
of the cell membrane. In particular, the bacterium responds
by altering the cis to trans ratio and by modifying the phos-
pholipid headgroups [14–17]. Second, the bacterium has an
exquisite set of tools ready to respond to unexpected situa-
tions, and uses a kind of general stress response involving a
series of chaperones and DNA repair systems to overcome
toxic effects [18–20]. The third mechanism, probably the
most important, involves the series of efﬂux pumps that
remove toxic chemicals from the cell. An important point is
that tolerance to toxic chemicals and antimicrobials can be
greatly inﬂuenced by the conditions under which bacteria are
grown. For instance, when P. putida strains are grown in the
absence of the solvent toluene and are then suddenly
exposed to 0.3% (v/v) toluene, only a small fraction of the
cells, about one in 10 000, survive the shock [21]. However,
if the strains are precultured in the presence of low concen-
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Fig. 1. Illustration showing the main types of bacterial efﬂux systems. Indicated are TtgABC from Pseudomonas putida (a member of the root–
nodulation–cell division (RND) family), LmrA from Lactococcus lactis (a member of the ATP-binding cassette (ABC) family) and NorA from Staph-
ylococcus aureus (a member of the major facilitator superfamily (MFS) family). As mentioned in the text, there are two other main types of efﬂux
systems found in bacteria, small multidrug resistance (SMR) and multi-antimicrobial extrusion (MATE), and both systems appear to be structurally
similar to the MFS family of pumps.
CMI Daniels and Ramos Adaptive drug resistance 33
ª2009 The Authors
Journal Compilation ª2009 European Society of Clinical Microbiology and Infectious Diseases, CMI, 15 (Suppl. 1), 32–36
trations of toluene, 50–100% of the cells survive a sub-
sequent solvent shock. These results suggest that some
aspects of solvent tolerance involve the induction of multiple
solvent tolerance determinants [22].
To investigate the role of different elements in solvent tol-
erance and antibiotic resistance, our research group looked
for solvent-sensitive mutants via generalized mini-Tn5 muta-
genesis. One such mutant is P. putida DOT-T1E-18, which, in
contrast to the wild-type strain, was not able to tolerate a
sudden toluene shock and also showed signiﬁcantly dimi-
nished induced tolerance [21]. We also tested this strain for
antibiotic tolerance, and found a concomitant increase in
antibiotic sensitivity [23]. Sequencing of the DNA adjacent to
the mini-Tn5 insertion revealed that DOT-T1E-18 had a
knockout in an operon that encoded a solvent exclusion
RND efﬂux pump, which we called TtgABC. This pump is
expressed at a basal level from a single promoter when the
bacteria are grown under laboratory culture conditions [24].
The proteins TtgABC consist of the pump itself (TtgB),
located in the inner membrane, and a porin (TtgC) that
crosses the outer membrane and penetrates through the
periplasm to reach the pump [5]. This outer membrane pro-
tein generates a channel through which toxic chemicals are
extruded. The interactions between TtgB and TtgC are
maintained by a lipoprotein (TtgA) that is ﬁxed to the inner
membrane [25].
Expression of the ttgABC operon is controlled by TtgR
(Fig. 2); ttgA and ttgR are transcribed divergently and, based
on the determination of their corresponding transcription
start points, their promoters overlap [24]. Recently, we
puriﬁed TtgR to homogeneity in our laboratory and found
that TtgR is a dimer in solution and is able to bind to the
intergenic region between ttgR and ttgA, as shown by electro-
phoretic mobility shift assays (EMSAs). DNaseI footprints
revealed that TtgR protected four helical turns in the pro-
moter region; more speciﬁcally, it bound a 30-bp operator.
The stoichiometry of TtgR binding to target DNA was deter-
mined by carrying out a series of equilibrium centrifugation
analyses, which revealed that one dimer was bound per
operator [26].
Using isothermal titration calorimetry, Krell et al. [26]
showed that TtgR binds with relatively high afﬁnity (100 nM)
to its target operator. The sequence of the operator to
which TtgR binds revealed that the target could be an over-
lapping inverted repeat.
A series of early competition assays revealed that the
TtgABC efﬂux pump removes toluene, xylene, styrene, naph-
thalene and other aromatic compounds [11]. Tera´n et al.
[23,27,28] have shown that the efﬂux pump also removes
antibiotics and ﬂavonoids. Subsequently, using EMSA, we
tested whether the induction of the efﬂux pump occurred in
response to the compounds extruded by the pump. Our
rationale was that in the absence of effectors, TtgR binds
and retards DNA. If TtgR interacts with a drug, the protein
should be released and DNA should not be retarded. Among
the TtgR effectors there are antibiotics (chloramphenicol,
tetracycline and ampicillin) and ﬂavonoids (naringenin and
phloretin), but not hydrocarbons [27].
The afﬁnity of TtgR in solution and bound to DNA for its
effectors was determined by microcalorimetric titration with
free and DNA-bound protein. An extensive series of kinetic
analyses allowed Krell et al. [26] to determine that the
afﬁnity was in the low micromolar range. Alguel et al. [29]
also established, through equilibrium analysis, that each TtgR
dimer binds one effector molecule both in solution and when
bound to DNA.
The ttgABC operon is not transcribed when TtgR is bound to the promotor
The ttgABC operon is transcribed in the presence of antibiotics and flavonoids
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Fig. 2. Regulation of ttgABC, a root–nodula-
tion–cell division (RND) family efﬂux pump
from Pseudomonas putida DOT-T1E. (a) When
a wild-type strain is grown in the absence of
effector molecules such as antibiotics, the
TtgR protein is produced and binds to the
promoter/operator site, thus preventing fur-
ther transcription and expression of the
ttgABC operon. (b) In the presence of ﬂavo-
noids and antibiotics, the repression is
removed because effector molecules are able
to bind to the TtgR repressor and prevent
binding of the repressor to the promoter/
operator region.
34 Clinical Microbiology and Infection, Volume 15, Supplement 1, January 2009 CMI
ª2009 The Authors
Journal Compilation ª2009 European Society of Clinical Microbiology and Infectious Diseases, CMI, 15 (Suppl. 1), 32–36
The TtgR protein, which belongs to the TetR family of
regulators, has recently been crystallized alone and with sev-
eral different effectors [29]. It has a highly conserved struc-
ture and, like TetR [30] and QacR [31], is composed of nine
a-helices, with a2 and a3 constituting the HTH DNA-binding
domain. Co-crystallization of TtgR with effectors revealed
that the binding pocket of this regulator has a wide cavity
that allows it to interact with a multitude of effector mole-
cules by establishing different van der Waals and ionic
bridges with numerous amino acids in the effector binding
pocket [29]. It was shown that phloretin binds with high
afﬁnity to residues His114, Arg130 and Arg176. Tetracycline
and other ﬂavonoids, however, bind with low afﬁnity in a dif-
ferent binding pocket. We have recently generated eight
independent mutations in residues involved in the binding
pocket. We have puriﬁed each of the mutant proteins and
conducted EMSAs. We found that some of the amino acid
changes in this region of TtgR result in a marked increase in
afﬁnity for the operator DNA and a subsequent decrease in
afﬁnity for certain effector molecules (C. Daniels, unpub-
lished results), suggesting that we have identiﬁed the effec-
tor-binding pocket.
In summary, multidrug efﬂux pumps are able to extrude a
wide range of chemicals and can be speciﬁcally induced in
response to certain compounds. These traits can lead to an
increase in the level of resistance to all drugs extruded by
the pump. Therefore, the use of non-antibiotic chemicals in
household cleaning products may inﬂuence the efﬁciency of
hospital drugs, both biocides and antimicrobials, because of
acquired and induced resistance.
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